OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study
Talal El Zarif, Karl Semaan, Wanling Xie, et al.
European Urology (2024) Vol. 86, Iss. 6, pp. 503-512
Closed Access | Times Cited: 7
Talal El Zarif, Karl Semaan, Wanling Xie, et al.
European Urology (2024) Vol. 86, Iss. 6, pp. 503-512
Closed Access | Times Cited: 7
Showing 7 citing articles:
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma
Jens Bedke, Yasmin Abu Ghanem, Laurence Albigès, et al.
European Urology (2025)
Closed Access | Times Cited: 1
Jens Bedke, Yasmin Abu Ghanem, Laurence Albigès, et al.
European Urology (2025)
Closed Access | Times Cited: 1
B2B: Kidney Cancer Summary
Simon Tanguay, Maxine Tran, Vedang Murthy, et al.
Société Internationale d’Urologie Journal (2025) Vol. 6, Iss. 1, pp. 15-15
Open Access
Simon Tanguay, Maxine Tran, Vedang Murthy, et al.
Société Internationale d’Urologie Journal (2025) Vol. 6, Iss. 1, pp. 15-15
Open Access
Recent Developments in the Management of Renal Cell Cancer
Yu‐Wei Chen, Justine Panian, Brent S. Rose, et al.
JCO Oncology Practice (2025)
Closed Access
Yu‐Wei Chen, Justine Panian, Brent S. Rose, et al.
JCO Oncology Practice (2025)
Closed Access
Management of Kidney Cancer Relapse to Adjuvant Pembrolizumab: Early Insights and Questions for a Newly Emerging Space
Martin H. Voss, Robert J. Motzer
European Urology (2024) Vol. 86, Iss. 6, pp. 513-515
Closed Access
Martin H. Voss, Robert J. Motzer
European Urology (2024) Vol. 86, Iss. 6, pp. 513-515
Closed Access
Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types
Karl Semaan, Rashad Nawfal, Elizabeth Nally, et al.
The Lancet Oncology (2024)
Closed Access
Karl Semaan, Rashad Nawfal, Elizabeth Nally, et al.
The Lancet Oncology (2024)
Closed Access
Despite an Abundance of Active Treatment Options for Renal Cell Carcinoma, Shadows Still Obscure the Light
Camillo Porta, Carlo Ganini, Mimma Rizzo
European Urology (2024)
Closed Access
Camillo Porta, Carlo Ganini, Mimma Rizzo
European Urology (2024)
Closed Access
The role of ablative therapy for primary and oligometastatic renal cell carcinoma
Marc Eid, Karl Semaan, Eddy Saad, et al.
Kidney Cancer (2024) Vol. 8, Iss. 1, pp. 187-192
Open Access
Marc Eid, Karl Semaan, Eddy Saad, et al.
Kidney Cancer (2024) Vol. 8, Iss. 1, pp. 187-192
Open Access
